Symbols / BEAM $25.44 +3.88% Beam Therapeutics Inc.

Healthcare • Biotechnology • United States • NMS
BEAM Chart
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 2.59B
Enterprise Value 1.44B Income -79.99M Sales 139.74M
Book/sh 12.48 Cash/sh 12.54 Dividend Yield —
Payout 0.00% Employees 511 IPO —
P/E — Forward P/E -5.80 PEG —
P/S 18.54 P/B 2.04 P/C —
EV/EBITDA -3.97 EV/Sales 10.27 Quick Ratio 12.85
Current Ratio 13.09 Debt/Eq 12.45 LT Debt/Eq —
EPS (ttm) -0.84 EPS next Y -4.39 EPS Growth —
Revenue Growth 279.50% Earnings 2026-05-05 ROA -18.55%
ROE -8.11% ROIC — Gross Margin -193.12%
Oper. Margin -15.29% Profit Margin -57.24% Shs Outstand 101.86M
Shs Float 88.04M Short Float 23.48% Short Ratio 11.01
Short Interest — 52W High 36.44 52W Low 13.54
Beta 2.19 Avg Volume 2.01M Volume 1.82M
Target Price $51.20 Recom Strong_buy Prev Close $24.49
Price $25.44 Change 3.88%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-38.93
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest BEAM news

No recent news from Yahoo. Try the RSS feed for latest BEAM news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 CIARAMELLA GIUSEPPE President — 11,810 $24.58 $290,290
2026-04-01 EVANS JOHN M. Chief Executive Officer — 30,078 $24.58 $739,317
2026-04-01 BELLON CHRISTINE Officer — 5,956 $24.58 $146,398
2026-04-01 SIMON AMY Officer — 6,700 $24.58 $164,686
2026-04-01 CAVANAGH BETHANY J Officer and Treasurer — 3,242 $24.58 $79,688
2026-03-31 CIARAMELLA GIUSEPPE President — 40,000 $0.00 $0
2026-03-31 EVANS JOHN M. Chief Executive Officer — 90,000 $0.00 $0
2026-03-31 EVANS JOHN M. Chief Executive Officer — 50,000 $22.37 $1,128,315
2026-03-31 EVANS JOHN M. Chief Executive Officer — 50,000 $0.67 $33,500
2026-03-31 EMANY SRAVAN KUMAR Chief Financial Officer — 31,750 $0.00 $0
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category